Research and Markets - Global Facial Aesthetics Market 2016-2020 with Allergan, Galderma SA, Ipsen Pharmaceuticals & Merz Pharma Dominating
DUBLIN, May 12, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Facial Aesthetics Market 2016-2020" report to their offering.
The global facial aesthetics market to grow at a CAGR of 9.82% during the period 2016-2020.
Global Facial Aesthetics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Medical aesthetics is a fusion of healthcare and beauty services to provide high-technology skin care that involves significant cosmetic change or enhancement. The treatments employed include injections of Botox and dermal facial fillers, body contouring, laser hair removal, chemical peels, breast and dental implantation, and microdermabrasions. Plastic surgeons and dermatologists perform all these procedures on patients who are under local anesthesia.
There is a growing desire among people to stay youthful and maintain an attractive appearance. These days, men as well as women are determined to look and feel better. It boosts their self-confidence and self-esteem and helps them gain acceptability in social situations and at work. This has resulted in the increased adoption of beautification products to enhance beauty and physical appearance.
According to the report, Shift from invasive to minimally invasive and non-invasive procedures is one of the major drivers in the market. Minimally invasive and non-invasive procedures have smaller incisions, less pain, reduced scarring, and lower incidences of post-surgical complications such as adhesions and wound dehiscence, thus helping in speedy recovery. In 2014, the American Society for Aesthetic Plastic Surgery estimated that the use of non-invasive aesthetic procedures had increased in the US, accounting for 84% of the overall medical aesthetic procedures.
Further, the report states that side effects associated with facial aesthetics products are restricting the market growth.
To calculate the market size, the report considers the revenue generated from the sale of following types of facial aesthetics product types:
- Botox (Botulinum toxin) - Dermal fillers - Other (chemical peel and microdermabrasion)
Key vendors
- Allergan - Galderma SA - Ipsen Pharmaceuticals - Merz Pharma
Other prominent vendors
- Hangzhou Techderm Biological Products - Laboratory Obvieline - Medytox - Polymekon - Qufu Guanglong Biochem - Revitacare - SciVision Biotech - Sinclair Pharma - Speciality European Pharma - Suneva Medical - Syneron - Teoxane - Valeant Pharmaceuticals - Visionmed
For more information visit http://www.researchandmarkets.com/research/zv49rm/global_facial
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article